Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation - Wikidata - awgldk - TriplyDB

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

http://www.wikidata.org/entity/Q29615439

about

Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity Cell-specific subcellular localization of soluble epoxide hydrolase in human tissues Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase Protein quaternary structure and expression levels contribute to peroxisomal-targeting-sequence-1-mediated peroxisomal import of human soluble epoxide hydrolase Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2 Reprogramming: A Preventive Strategy in Hypertension Focusing on the Kidney Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function Mechanism of the sex difference in endothelial dysfunction after stroke Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism Inside epoxyeicosatrienoic acids and cardiovascular disease Cytochrome P450 eicosanoids in hypertension and renal disease Soluble epoxide hydrolase: A potential target for metabolic diseases Soluble epoxide hydrolase: gene structure, expression and deletion Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase Soluble epoxide hydrolase inhibitors and heart failure Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation Targeting epoxides for organ damage in hypertension Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia Epoxyeicosatrienoic acids, hypertension, and kidney injury Red blood cells (RBCs), epoxyeicosatrienoic acids (EETs) and adenosine triphosphate (ATP)Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

P2860

Q23910189-AE6DABA4-8263-44D3-A0CF-3B5B0A005742 Q23911282-8D519F6B-DAD8-4B65-8DC6-05910F6B8AC0 Q24294364-31B7735E-28A3-4800-B5C6-826C673D1B82 Q24294384-C272112F-0A84-40F7-8E78-129595D7F9B3 Q24297113-E829E9D5-7531-43BF-8D67-92E8362D8937 Q24310374-DF268943-9FE3-4EC5-BC55-CDE8083361A2 Q24317892-62423F0E-5E95-4114-938A-8888E004C46F Q24546215-DA243EC1-9F0A-432F-957A-3E1160981F22 Q24597172-652BFED5-9AA4-479A-998E-30C42C8942B8 Q24618018-8813B46A-A782-4F10-8C1F-0C2AB428EA4C Q24642280-457DDB90-71FD-4421-BA78-1BA66491FC0C Q26771815-FC0E0614-E637-44F1-868A-22AA61EA4AD4 Q26849271-99EE6A1E-3BDB-49F5-AFC7-B11468EF1FBF Q27001603-0693D654-BEAD-430E-A048-E5E3FFA16DBA Q28245279-64A14ACF-66C1-432D-9DDC-778DF9CA16F1 Q28252156-C50B994F-430B-443E-BC9E-12A9A869CF50 Q28252210-4288DC0E-74CA-42AB-8585-E80A59998057 Q28270454-3D201467-3FD3-4827-849E-446938FC9909 Q28291292-F9C3172E-BE0A-477D-976C-A55CB787AEE3 Q28302779-53D99FB6-6F33-4590-83D7-85A3B4746DB6 Q28383423-C3F3C83C-E5AA-4C92-A1C8-6A0C4719AF7F Q28383719-1B5B8B95-7159-4320-A00A-F1F7A1F3191D Q28384214-C6CEE6DC-CA42-41D7-8A55-B323E79B24B9 Q28384254-298397EB-968B-42A9-9C7D-A7275601496B Q28384279-A6F6E367-BD30-4C5C-8619-5104E6D22E5E Q28385015-71B6C55C-1F4D-44CB-8E16-B950B78B32EB Q28385478-C7215D9A-36B3-438E-A217-EC6623A13116 Q28385835-8D9E50C0-1683-43AA-B17F-94C526B4374B Q28386324-425A5572-E4BD-4362-8F35-81B26EBCC363 Q28387558-5BA33DFB-FB4A-44CB-B8BE-2FE648D69951 Q28387764-5CA594F6-FA7C-40B5-B7A0-F4E74FAC144B Q28387823-9D05901E-F82C-4028-947B-EC19A3536610 Q28388012-228DCA31-7CC9-4BFD-B771-182C8B0C6D26 Q28388202-801225A7-C236-4735-A35C-63E5939DCD46 Q28388993-08E3F326-F9E3-4335-A849-61353A038D47 Q28390217-296D2131-60B3-4700-84D0-BA6B2095A8D1 Q28390972-A7096FD5-BD7C-4ED3-B1DC-B35899BCA5B2 Q28391163-FE54B7D9-DEEE-470B-AFD0-F8F380DA0B06 Q28391533-DB8E72D3-D5AA-4D10-BCB1-5DB4F2ED6779 Q28391736-87A23A0D-EDF5-4B36-BFA2-F22A93E079AD

P2860

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

http://www.wikidata.org/entity/Q29615439

description

2000 nî lūn-bûn

@nan

2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Targeted disruption of soluble ...... e in blood pressure regulation

@ast

Targeted disruption of soluble ...... e in blood pressure regulation

@en

type

label

Targeted disruption of soluble ...... e in blood pressure regulation

@ast

Targeted disruption of soluble ...... e in blood pressure regulation

@en

prefLabel

Targeted disruption of soluble ...... e in blood pressure regulation

@ast

Targeted disruption of soluble ...... e in blood pressure regulation

@en

P1433

Q29615439-5D44631D-2A19-435C-928F-EAC6B1298F70

P1476

Q29615439-39A16D28-EB03-4C17-BE09-C85FB391120B

P2093

Q29615439-0165F9A8-E1A5-485C-8C71-23BFA2AD0E73

Q29615439-019790CD-E841-408D-80BE-BA5773797FF1

Q29615439-3BA25A07-A2B0-4C76-9D42-C6884D1732CD

Q29615439-694EF307-0A3C-4214-B2D5-3D678E644CD2

Q29615439-889C6E25-3687-4957-B1C3-12FEAAF7C616

Q29615439-EDE08EAB-BB56-423A-90F1-9541D911ECDF

P304

Q29615439-17AC22B1-E47F-482A-8184-D67AE526CC43

P31

Q29615439-4BD2914C-669A-4B21-8EF2-6D5DE485811E

P3181

Q29615439-52D6199D-1F56-4736-8FD2-70F16A867A66

P356

Q29615439-5B0FB3B9-F0C6-42A2-AB6A-5A0595E40F3E

P407

Q29615439-C24289D2-C83B-4521-9311-734EE9CDCEC7

P433

Q29615439-98A6BF6F-A3AC-4560-90A1-0EA831C259C9

P478

Q29615439-53F9E754-9CEE-482C-B7F3-BE41FF011D7A

P577

Q29615439-DA2710EC-4035-468D-9C74-3D8FE6D030C0

P5875

Q29615439-54D2D35B-9430-4931-A8CA-7E30E8EB43CA

P698

Q29615439-2B419CBC-C2D8-4B63-BBB6-FF07838896A8

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Targeted disruption of soluble ...... e in blood pressure regulation

@en

P2093

Bend JR

http://www.w3.org/2001/XMLSchema#string

Gonzalez FJ

http://www.w3.org/2001/XMLSchema#string

Miyata M

http://www.w3.org/2001/XMLSchema#string

Nagata K

http://www.w3.org/2001/XMLSchema#string

Sinal CJ

http://www.w3.org/2001/XMLSchema#string

Tohkin M

http://www.w3.org/2001/XMLSchema#string

P304

40504-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1833228

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M008106200

http://www.w3.org/2001/XMLSchema#string

P407

P433

51

http://www.w3.org/2001/XMLSchema#string

P478

275

http://www.w3.org/2001/XMLSchema#string

P577

2000-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12321512

http://www.w3.org/2001/XMLSchema#string

P698

11001943

http://www.w3.org/2001/XMLSchema#string